Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT

Journal of Photochemistry and Photobiology B: Biology

Volumn 96, Issue 1, 2009, Pages 1-8

  Robertson, C A ^a   Evans, D Hawkins ^a   Abrahamse, H ^a  

^a UNIVERSITY OF JOHANNESBURG   (South Africa)

Author keywords

Cellular mechanisms; PDT mechanisms; Photochemistry; Photodynamic therapy; Photosensitizers; Tumor destruction

Indexed keywords

CALCIUM; CELL ADHESION MOLECULE; CYTOKINE; PHOTOSENSITIZING AGENT; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR;

ANGIOGENESIS; APOPTOSIS; CANCER THERAPY; CELL DEATH; CELL HYPOXIA; CELL METABOLISM; CELL STRESS; CELL TRANSPORT; CELLULAR DISTRIBUTION; DNA DAMAGE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; HUMAN; LIPID METABOLISM; MOLECULAR PHYSICS; NONHUMAN; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; HUMANS; NEOPLASMS; PHOTOCHEMISTRY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 67349201695     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2009.04.001     Document Type: Review

References (34)

1. Kubler A.C. Photodynamic therapy. Med. Laser Appl. 20 (2005) 37-45
2. Mitra A., and Stables G.I. Topical photodynamic therapy for non-cancerous skin conditions. Photodiag. Photodyn. Ther. 3 (2006) 116-127
3. Schuitmaker J.J., Bass P., Van Leengoed H.L.L.M., Van Der Meulen F.W., Star W.M., and Zandwijk N. Photodynamic therapy: a promising new modality for the treatment of cancer. J. Photochem. Photobiol.: B. Biol. 34 (1996) 3-12
4. Castano A.P., Demidova T.N., and Hamblin M.R. Mechanisms in photodynamic therapy: part two - cellular signalling, cell metabolism and modes of cell death. Photodiag. Photodyn. Ther. 2 (2005) 1-23
5. Alexiades-Armenakas M. Laser-mediated photodynamic therapy. Clin. Dermatol. 24 (2006) 16-25
6. Brown S.B., Brown E.A., and Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5 (2004) 497-508
7. De Rosa F.S., and Bentley M.V.L.B. Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives. Pharm. Res. 17 (2000) 1447-1455
8. Castano A.P., Demidova T.N., and Hamblin M.R. Mechanisms in photodynamic therapy: Part two - photosensitizers, photochemistry and cellular localization. Photodiag. Photodyn. Ther. 1 (2004) 279-293
9. Juzeniene A., and Moan J. The history of PDT in Norway. Part one - identification of basic mechanisms of general PDT. Photodiag. Photodyn. Ther. 4 (2007) 3-11
10. Ochsner M. Light scattering of human skin: a comparison between zinic(II)-pthalocyanine and photofrin II. J. Photochem. Photobiol.: B. Biol. 32 (1996) 3-9
11. Plaetzer K., Krammer B., Berlanda J., Berr F., and Kiesslich T. Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Laser. Med. Sci. 1 (2008) 1-15
12. Pazos M.D.C., and Nader H.B. Effect of photodynamic therapy on the extracellular matrix and associated components. Braz. J. Med. Biol. Res. 40 (2007) 1025-1035
13. Saikali S., Avril T., Collet B., Hamlat A., Bansard J., Drenou B., Guegan Y., and Quilien V. Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ra2, gp100 and TRP-2 for immunotherapy. J. Neurooncol. 81 (2007) 139-148
14. Nowis D., Stoklosa T., Legat M., Issat T., Jakobisiak M., and Golab J. The influence of photodynamic therapy on the immune response. Photodiag. Photodyn. Ther. 2 (2005) 283-298
15. Haqq C., Nosrati M., Sudilovsky D., Crothers J., Khodabakhsh D., Pulliam B.L., Federman S., Miller J.R., Allen R.E., Singer M.I., Leong S.P.L., Liung B., Sagebiel R.W., and Kashani-Sabet M. The gene expression signatures of melanoma progression. Nat. Acad. Sci. 17 (2005) 6092-6097
16. Santonocito C., Concolino P., Lavieri M.M., Ameglio F., Gentileschi S., Capizzi R., Rocchetti S., Amerio P., Castagnola M., Zuppi C., and Capoluongo E. Comparison between three molecular methods for detection of blood melanoma tyrosinase mRNA. Correlation with melanoma stages and S100B, LDH, NSE biochemical markers. Clin. Chim. Acta 362 (2005) 85-95
17. Davids L.M., Kleemann B., Kacerovska D., Pizinger K., and Kidson S.H. Hypericin phototoxicity induces different modes of cell death in melanoma and human skin cells. J. Photochem. Photobiol.: B. Biol. 91 (2008) 67-76
18. Zhen-hui Peng M.P., Xiao S., Ren J., Liu Y., Li X., and Li Z. Apoptotic effect and mechanisms of AHPN on human skin malignant melanoma cell A375. J. Nanjing Med. Univ. 22 (2008) 18-22
19. Buytaert E., Dewaele M., and Agostinis P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochem. Biophys. Acta 1776 (2007) 86-107
20. Huang Y., Lee T., Chan K., Hsu F., Wu Y., and Lee M. Anemonin is a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes. J. Dermatol. Sci. 49 (2008) 115-123
21. Roland C.L., Harken A.H., Sarr M.G., and Barnett C.C. Evidence-based surgical hypothesis: ICAM-1 expression determines malignant potential of cancer. J. Surg. 141 (2007) 705-707
22. Anstey A. Photodynamic therapy. Med. Treat. - Med. Pub. Comp. Ltd. 32 (2004) 24-25
23. MacCormack M.A. Photodynamic therapy in dermatology: an update on applications and outcomes. Semin. Cutan. Med. Surg. 27 (2008) 52-62
24. Juzeniene A., and Moan J. The history of PDT in Norway. Part two: recent advances in general PDT and ALA-PDT. Photodiag. Photodyn. Ther. 4 (2007) 80-87
25. Miller J.D., Baron E.D., Scull H., Hsia A., Berlin J.C., McCormick T., Colussi V., Kenny M.E., Cooper K.D., and Oleinick N.L. Photodynamic therapy with the phthalocyanine photosensitizer Pc4: the case experience with preclinical mechanisitic and early clinical-translational studies. Toxicol. Appl. Pharm. 244 (2007)
26. Kolaoova H., Kubinek R., and Strnad M. Assesment of cellular damage by inverted fluorescent microscopy. Sci. Tech. Educ. Microsci. 1 (2000) 464-468
27. Ketabchi A., MacRobert A., Speight P.M., and Bennett J.H. Induction of apoptotic cell death by photodynamic therapy in human kerationcytes. Arch. Oral. Biol. 43 (1998) 143-149
28. Buggiani G., Troiano M., Rossi R., and Lotti T. Photodynamic therapy: off-label and alternative use in dermatological practice. Photodiag. Photodyn. Ther. 1 (2008) 1-5
29. Castano A.P., Demidova T.N., and Hamblin M.R. Mechanisms in photodynamic therapy: part three - photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiag. Photodyn. Ther. 2 (2005) 91-106
30. Timar J., Meszaros L., Ladanyi A., Puskas L.G., and Raso E. Melanoma genomics reveals signatures of sensitivity to bio- and targeted therapies. Cell. Immunol. 244 (2006) 154-157
31. Sieron A., Kawczyk-Krupa A., Adamek M., Cebula W., Zieleznick W., Niepsuj G., Pietrusa A., Szygula M., Biniszkiewicz T., Mazur S., Malyszek J., Romanczyk A., Ledwon A., Frankiewicz A., Zybura A., Koczy E., and Birkner B. Photodynamic diagnosis (PDD) and photodynamic therapy (PDT) in dermatology: "How we do it". Photodiag. Photodyn. Ther. 3 (2005) 132-133
32. Liu Y., Suwa F., Wang X., Takemura A., Fang Y.R., Li Y., Zhao Y., and Jin Y. Reconstruction of a tissue-engineered skin containing melanocytes. Cell Biol. Int. 31 (2007) 985-990
33. Odashiro A.N., Pereira P.R., Marshall J., Goderio K., and Burnier M.N. Skin cancer models. Drug Discov. Today: Disease Mod. 2 (2005) 71-75
34. Allison R.R., Cuenca R.E., Downie G.H., Camnitz P., Brodish B., and Sibata C.H. Clinical photodynamic therapy of head and neck cancers - a review of applications and outcomes. Photodiag. Photodyn. Ther. 2 (2005) 205-222